Pharmaceutical News

RSS

New collaboration to investigate forms of RNA modification

Universität Mainz Institute of Pharmaceutical and Biomedical Sciences of Mainz University to collaborate with Monash University and ETH Zurich to investigate forms of RNA modification.

27 Jul 2023

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.

26 Jul 2023

Tumor-derived GDF-15 suppresses immunotherapy response

Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.

26 Jul 2023

Drug interferon proven effective to reduce the spread of COVID-19

Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.

26 Jul 2023

Study identifies barriers to prescribing medications for alcohol use disorder in primary care

Researchers explored how primary care physicians who have some familiarity with medications for alcohol use disorder (MAUD) make prescribing decisions and identify reasons for the underuse of MAUD in primary care.

25 Jul 2023

Meclofenamate shows promise in treating abnormal respiratory mucus

Our respiratory system is lined with a thin fluid layer called mucus on the inside. The mucus protects us from inhaling harmful and unwanted airborne agents from germs to pollutants; it achieves this feat due to its unique gel-like texture imparted by proteins called mucins.

25 Jul 2023

Single target, multiple possibilities: microRNA holds promise for epilepsy treatment

Study investigated the role of micro-ribonucleic acid (miRNA) miR-335-5p as a potential therapeutic target for epilepsy.

25 Jul 2023

New weight loss drugs carry high price tags and lots of questions for seniors

Corlee Morris has dieted throughout her adult life.

25 Jul 2023

Researchers uncover the biology behind insulin production

The discovery of insulin has saved the lives of millions of people with diabetes worldwide, but little is known about the first step of insulin synthesis.

25 Jul 2023

Advancing new antibiotics through the later stages of clinical testing

A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics.

25 Jul 2023

Designing vaccines to induce a stronger immune response to infecting pathogens

A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19.

25 Jul 2023

Inflation Reduction Act's $35 insulin cap linked to rise in prescription fills

The Inflation Reduction Act's policy capping out-of-pocket costs for insulin to $35 for a month's supply led to increases in the total number of insulin fills for Medicare beneficiaries, according to a new study from the USC Schaeffer Center for Health Policy & Economics and University of Wisconsin–Madison.

24 Jul 2023

Could alpha lipoic acid treat polycystic ovary syndrome?

Authors analyzed the efficacy of alpha lipoic acid (ALA) in treating polycystic ovary syndrome (PCOS).

24 Jul 2023

New class of cholesterol-lowering drugs can affect lung function and brain size, study finds

One of the world’s largest studies on the impact of cholesterol-lowering medication has highlighted an issue with a new class of drugs that could impair lung function in some patients.

24 Jul 2023

New INTREPID Alliance aims to speed up development of antivirals for future pandemics

Seven innovative pharmaceutical companies have established the INTREPID Alliance with the goal of accelerating progress in discovery and development of new antiviral treatments for future pandemics.

24 Jul 2023

New brain-penetrant agonist shows promise in protecting dopamine neurons for Parkinson's disease treatment

Researchers reported on Nurr1 as a promising therapeutic target for managing Parkinson's disease (PD).

20 Jul 2023

Donanemab: A trailblazer for Alzheimer's disease treatment?

A recent study evaluated the efficacy and side effects of donanemab, an antibody that could possibly clear brain amyloid plaque in early symptomatic Alzheimer disease (AD).

20 Jul 2023

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Caffeine has a dual role in headaches as it can induces or remediate them.

20 Jul 2023

Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress

It's time to stop prevaricating and explore the use of psilocybin—the active ingredient in 'magic mushrooms'—and other psychedelics to ease the often overwhelming distress faced by women with late stage gynecological cancers, urge doctors in a commentary published online in the International Journal of Gynecological Cancer.

19 Jul 2023

Researchers convert β-Pinene into renewable feedstock for sustainable paracetamol and ibuprofen

Researchers have developed scalable processes to convert β-pinene into 4-IPEC, a feedstock for synthesizing sustainable versions of paracetamol and ibuprofen.

19 Jul 2023

Previous
1
...
64
65
66
67
68
69
70
...
1453
Next

Pharmaceutical News

New collaboration to investigate forms of RNA modification

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

Tumor-derived GDF-15 suppresses immunotherapy response

Drug interferon proven effective to reduce the spread of COVID-19

Study identifies barriers to prescribing medications for alcohol use disorder in primary care

Meclofenamate shows promise in treating abnormal respiratory mucus

Single target, multiple possibilities: microRNA holds promise for epilepsy treatment

New weight loss drugs carry high price tags and lots of questions for seniors

Researchers uncover the biology behind insulin production

Advancing new antibiotics through the later stages of clinical testing

Designing vaccines to induce a stronger immune response to infecting pathogens

Inflation Reduction Act's $35 insulin cap linked to rise in prescription fills

Could alpha lipoic acid treat polycystic ovary syndrome?

New class of cholesterol-lowering drugs can affect lung function and brain size, study finds

New INTREPID Alliance aims to speed up development of antivirals for future pandemics

New brain-penetrant agonist shows promise in protecting dopamine neurons for Parkinson's disease treatment

Donanemab: A trailblazer for Alzheimer's disease treatment?

Study explores the effectiveness of caffeine consumption for headaches: trigger or remedy?

Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress

Researchers convert β-Pinene into renewable feedstock for sustainable paracetamol and ibuprofen

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News